Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.

Publication date

2008

Authors

Wijngaarden, S.
Van De Winkel, Jan G.J.ISNI 0000000083658940
Bijlsma, Johannes W JISNI 0000000358198681
Lafeber, Floris P J GISNI 0000000393082668
van Roon, Joel A.G.ISNI 0000000390928883

Editors

Advisors

Supervisors

DOI

Document Type

Article
Open Access logo

License

Abstract

Keywords

Citation

Wijngaarden, S, van de Winkel, J G J, Bijlsma, J W J, Lafeber, F P J G & van Roon, J A G 2008, 'Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.', Clinical and Experimental Rheumatology, vol. 26, no. 1, pp. 89-95.